Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 840 | 1,590 | 1,300 | 2,350 | 1,530 |
| TOTAL | $840 | $1,590 | $1,300 | $2,350 | $1,530 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 3,740 | 2,670 | 3,330 | 5,070 | 4,850 |
| TOTAL | $3,740 | $2,670 | $3,330 | $5,070 | $4,850 |
| Total Assets | $4,580 | $4,260 | $4,630 | $7,420 | $6,380 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 170 | 290 | 390 | 210 | 610 |
| Accrued Expenses | 4,320 | 4,510 | 4,010 | 4,610 | 4,540 |
| Other current liabilities | 410 | 460 | 910 | 340 | 350 |
| TOTAL | $5,480 | $6,000 | $6,140 | $5,900 | $6,320 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 4,300 | 4,410 | 3,840 | 3,090 | 3,080 |
| TOTAL | $4,830 | $4,990 | $4,510 | $3,970 | $4,000 |
| Total Liabilities | $10,310 | $10,990 | $10,650 | $9,870 | $10,320 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 20 | 20 | 20 | 20 |
| Other shareholders' equity | -60 | 1,030 | 1,850 | 810 | 250 |
| TOTAL | $249,260 | $209,060 | $208,200 | $200,420 | $198,860 |
| Total Liabilities And Equity | $259,570 | $220,050 | $218,850 | $210,290 | $209,180 |